Heubach Colorants India 과거 수익 실적
과거 기준 확인 1/6
Heubach Colorants India의 수입은 연평균 -22%의 비율로 감소해 온 반면, Chemicals 산업은 수입이 연평균 14.6%의 비율로 증가했습니다. 매출은 연평균 2.6%의 비율로 감소해 왔습니다. Heubach Colorants India의 자기자본이익률은 7.2%이고 순이익률은 4.6%입니다.
주요 정보
-22.0%
수익 성장률
-22.0%
EPS 성장률
Chemicals 산업 성장 | 17.7% |
매출 성장률 | -2.6% |
자기자본 수익률 | 7.2% |
순이익 | 4.6% |
최근 수익 업데이트 | 30 Sep 2024 |
최근 과거 실적 업데이트
Recent updates
We Think You Can Look Beyond Heubach Colorants India's (NSE:HEUBACHIND) Lackluster Earnings
Nov 22What Heubach Colorants India Limited's (NSE:HEUBACHIND) 26% Share Price Gain Is Not Telling You
Oct 12Is Heubach Colorants India (NSE:HEUBACHIND) A Risky Investment?
Oct 01Heubach Colorants India Limited (NSE:HEUBACHIND) Surges 29% Yet Its Low P/E Is No Reason For Excitement
Jun 22Here's Why Heubach Colorants India (NSE:HEUBACHIND) Can Manage Its Debt Responsibly
Feb 09A Look At The Intrinsic Value Of Clariant Chemicals (India) Limited (NSE:CLNINDIA)
Nov 16Shareholders May Not Be So Generous With Clariant Chemicals (India) Limited's (NSE:CLNINDIA) CEO Compensation And Here's Why
Aug 05Calculating The Intrinsic Value Of Clariant Chemicals (India) Limited (NSE:CLNINDIA)
Mar 10What Type Of Shareholders Own The Most Number of Clariant Chemicals (India) Limited (NSE:CLNINDIA) Shares?
Feb 12Is Clariant Chemicals (India) Limited's (NSE:CLNINDIA) Recent Stock Performance Influenced By Its Fundamentals In Any Way?
Jan 25Is Clariant Chemicals (India) Limited's (NSE:CLNINDIA) 2.9% Dividend Worth Your Time?
Jan 08Clariant Chemicals (India)'s (NSE:CLNINDIA) Earnings Are Growing But Is There More To The Story?
Dec 21A Look At Clariant Chemicals (India)'s (NSE:CLNINDIA) CEO Remuneration
Dec 02Reflecting on Clariant Chemicals (India)'s(NSE:CLNINDIA) Total Shareholder Returns Over The Last Five Years
Nov 14Weak Financial Prospects Seem To Be Dragging Down Clariant Chemicals (India) Limited (NSE:CLNINDIA) Stock
Oct 24Factors Income Investors Should Consider Before Adding Clariant Chemicals (India) Limited (NSE:CLNINDIA) To Their Portfolio
Oct 01What Kind Of Shareholders Own Clariant Chemicals (India) Limited (NSE:CLNINDIA)?
Sep 14How Does Clariant Chemicals (India)'s (NSE:CLNINDIA) CEO Salary Compare to Peers?
Aug 27Don't Buy Clariant Chemicals (India) Limited (NSE:CLNINDIA) For Its Next Dividend Without Doing These Checks
Aug 12Don't Race Out To Buy Clariant Chemicals (India) Limited (NSE:CLNINDIA) Just Because It's Going Ex-Dividend
Aug 12Clariant Chemicals (India) Limited's (NSE:CLNINDIA) Popularity With Investors Under Threat
Aug 12Clariant Chemicals (India) (NSE:CLNINDIA) Has Returned Negative 23% To Its Shareholders In The Past Five Years
Aug 10Clariant Chemicals (India) Limited's (NSE:CLNINDIA) Has Been On A Rise But Financial Prospects Look Weak: Is The Stock Overpriced?
Jul 26수익 및 비용 분석
수익 및 비용 분석
Heubach Colorants India 수익 창출 및 지출 방식. 최근 보고된 수익 기준, LTM 기준.
수익 및 매출 내역
날짜 | 수익 | 수익 | G+A 비용 | R&D 비용 |
---|---|---|---|---|
30 Sep 24 | 7,728 | 358 | 853 | 0 |
30 Jun 24 | 7,547 | 303 | 799 | 0 |
31 Mar 24 | 7,907 | 411 | 772 | 0 |
31 Dec 23 | 7,654 | 445 | 722 | 0 |
30 Sep 23 | 7,676 | 449 | 734 | 0 |
30 Jun 23 | 7,557 | 242 | 701 | 0 |
31 Mar 23 | 7,664 | 192 | 723 | 0 |
31 Dec 22 | 7,968 | 261 | 684 | 0 |
30 Sep 22 | 8,404 | 279 | 665 | 0 |
30 Jun 22 | 8,468 | 399 | 660 | 0 |
31 Mar 22 | 8,395 | 433 | 667 | 0 |
31 Dec 21 | 8,483 | 381 | 640 | 0 |
30 Sep 21 | 8,286 | 428 | 665 | 0 |
30 Jun 21 | 8,145 | 2,303 | 652 | 0 |
31 Mar 21 | 7,308 | 2,187 | 645 | 0 |
31 Dec 20 | 6,814 | 2,081 | 630 | 0 |
30 Sep 20 | 6,676 | 1,981 | 606 | 0 |
30 Jun 20 | 6,765 | 155 | 612 | 0 |
31 Mar 20 | 7,573 | 186 | 629 | 0 |
31 Dec 19 | 10,821 | 306 | 1,099 | 0 |
30 Sep 19 | 10,753 | 299 | 1,088 | 0 |
30 Jun 19 | 10,596 | 202 | 1,071 | 0 |
31 Mar 19 | 7,188 | 115 | 709 | 0 |
31 Dec 18 | 10,142 | 124 | 1,052 | 0 |
30 Sep 18 | 10,270 | 319 | 1,029 | 0 |
30 Jun 18 | 10,148 | 327 | 1,030 | 0 |
31 Mar 18 | 10,136 | 216 | 1,020 | 0 |
31 Dec 17 | 10,241 | 276 | 1,028 | 0 |
30 Sep 17 | 9,935 | 100 | 1,029 | 0 |
30 Jun 17 | 9,844 | 90 | 1,033 | 0 |
31 Mar 17 | 9,810 | 245 | 1,015 | 0 |
31 Dec 16 | 9,335 | -25 | 1,014 | 0 |
30 Sep 16 | 9,320 | 59 | 1,004 | 0 |
30 Jun 16 | 9,262 | 273 | 984 | 0 |
31 Mar 16 | 9,060 | 303 | 981 | 0 |
31 Dec 15 | 9,291 | 430 | 874 | 0 |
30 Sep 15 | 8,327 | 8,730 | 1,687 | 0 |
30 Jun 15 | 8,588 | 8,502 | 1,725 | 0 |
31 Mar 15 | 8,970 | 9,312 | 1,742 | 0 |
31 Dec 14 | 8,547 | 8,361 | 1,115 | 0 |
30 Sep 14 | 5,041 | 564 | 1,888 | 0 |
30 Jun 14 | 6,033 | 1,817 | 1,873 | 0 |
31 Mar 14 | 6,578 | 1,204 | 1,966 | 0 |
31 Dec 13 | 6,835 | 1,312 | 1,948 | 0 |
양질의 수익: HEUBACHIND 은 높은 수익을 보유하고 있습니다.
이익 마진 증가: HEUBACHIND 의 현재 순이익 이익률 (4.6%) 작년보다 낮습니다 (5.8%).
잉여현금흐름 대 수익 분석
과거 수익 성장 분석
수익추이: HEUBACHIND 의 수입은 지난 5년 동안 매년 22% 씩 감소했습니다.
성장 가속화: HEUBACHIND 은(는) 지난 1년 동안 마이너스 수익 성장을 기록했기 때문에 5년 평균과 비교할 수 없습니다.
수익 대 산업: HEUBACHIND 은 지난 1년 동안 마이너스 수익 성장( -20.1% )을 기록하여 Chemicals 업계 평균( 8% ).
자기자본 수익률
높은 ROE: HEUBACHIND 의 자본 수익률( 7.2% )은 낮음으로 간주됩니다.